Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
TKNO - Alpha Teknova Inc - Stock Price Chart
TickerTKNO [NASD]
CompanyAlpha Teknova Inc
CountryUSA
IndustryDrug Manufacturers - Specialty & Generic
Market Cap78.37MEPS (ttm)-1.05
P/E-EPS this Y42.67%
Forward P/E-EPS next Y14.66%
PEG-EPS past 5Y-113.92%
P/S2.13EPS next 5Y-
P/B0.94EPS Q/Q36.59%
Dividend-Sales Q/Q1.85%
Insider Own74.53%Inst Own14.67%
Insider Trans67.20%Inst Trans-1.24%
Short Float1.37%EarningsMay 13/a
Analyst Recom1.80Target Price5.00
Avg Volume225.60K52W Range1.15 - 4.27
LPA - Logistic Properties of the Americas - Stock Price Chart
TickerLPA [AMEX]
CompanyLogistic Properties of the Americas
CountryUSA
IndustryReal Estate - Development
Market Cap837.46MEPS (ttm)0.05
P/E549.06EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.08EPS Q/Q-133.94%
Dividend-Sales Q/Q-
Insider Own91.27%Inst Own0.68%
Insider Trans0.00%Inst Trans334.05%
Short Float0.66%Earnings-
Analyst Recom-Target Price-
Avg Volume381.38K52W Range5.59 - 525.00
CGA - China Green Agriculture Inc - Stock Price Chart
TickerCGA [NYSE]
CompanyChina Green Agriculture Inc
CountryChina
IndustryAgricultural Inputs
Market Cap34.02MEPS (ttm)-2.00
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y47.79%
P/S0.34EPS next 5Y12.50%
P/B0.30EPS Q/Q-5504.93%
Dividend-Sales Q/Q-27.23%
Insider Own44.86%Inst Own0.10%
Insider Trans0.00%Inst Trans-30.53%
Short Float0.64%Earnings-
Analyst Recom-Target Price-
Avg Volume5.63K52W Range1.61 - 4.00
GRNQ - Greenpro Capital Corp - Stock Price Chart
TickerGRNQ [NASD]
CompanyGreenpro Capital Corp
CountryMalaysia
IndustryConsulting Services
Market Cap9.63MEPS (ttm)0.08
P/E15.08EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S2.75EPS next 5Y-
P/B1.68EPS Q/Q-975.00%
Dividend-Sales Q/Q3.24%
Insider Own45.94%Inst Own1.09%
Insider Trans0.00%Inst Trans75.36%
Short Float0.39%Earnings-
Analyst Recom3.00Target Price8.00
Avg Volume206.01K52W Range0.72 - 1.88
ADTX - Aditxt Inc - Stock Price Chart
TickerADTX [NASD]
CompanyAditxt Inc
CountryUSA
IndustryBiotechnology
Market Cap4.62MEPS (ttm)-103.14
P/E-EPS this Y73.23%
Forward P/E-EPS next Y-
PEG-EPS past 5Y45.26%
P/S9.05EPS next 5Y-
P/B0.39EPS Q/Q82.57%
Dividend-Sales Q/Q-63.52%
Insider Own0.43%Inst Own0.91%
Insider Trans0.00%Inst Trans-
Short Float8.90%EarningsMay 29
Analyst Recom1.00Target Price61.00
Avg Volume536.05K52W Range1.35 - 68.08
KRO - Kronos Worldwide, Inc. - Stock Price Chart
TickerKRO [NYSE, RUT]
CompanyKronos Worldwide, Inc.
CountryUSA
IndustrySpecialty Chemicals
Market Cap1.27BEPS (ttm)-0.22
P/E-EPS this Y233.26%
Forward P/E13.23EPS next Y45.61%
PEG-EPS past 5Y-
P/S0.74EPS next 5Y-9.48%
P/B1.64EPS Q/Q153.41%
Dividend6.93%Sales Q/Q12.32%
Insider Own81.31%Inst Own15.46%
Insider Trans0.00%Inst Trans4.84%
Short Float3.50%EarningsMay 08/a
Analyst Recom3.67Target Price11.67
Avg Volume214.29K52W Range6.16 - 14.50
ERNA - Eterna Therapeutics Inc - Stock Price Chart
TickerERNA [NASD]
CompanyEterna Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap10.93MEPS (ttm)-4.25
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y0.06%
P/S91.07EPS next 5Y20.00%
P/B-EPS Q/Q-16.30%
Dividend-Sales Q/Q-
Insider Own48.42%Inst Own7.56%
Insider Trans0.00%Inst Trans-22.91%
Short Float1.95%Earnings-
Analyst Recom1.00Target Price60.00
Avg Volume7.66K52W Range0.84 - 2.96
May-14-24 10:53PM ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q1 2024 (InvestorPlace) +9.81% -9.79%
May-10-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire) -6.48%
May-08-24 09:31AM Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board (GlobeNewswire) +12.12%
May-07-24 08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on the Development of a mRNA-Engineered iPSC Line which Mimics Native B2M Expression, via Targeted Insertion of HLA-E at the B2M Locus (GlobeNewswire) +12.50%
08:00AM Eterna Therapeutics to Present at the ASGCT 27th Annual Meeting on Development of Beta 2 Microglobulin-Knockout (B2M-KO) iMSC Line with Enhanced Immunosuppressive Activity and Stealthing Features that May Further Augment the Therapeutic Potential of MSCs in Inflammatory Diseases (GlobeNewswire)
Mar-15-24 08:53AM ERNA Stock Earnings: Eterna Therapeutics Reported Results for Q4 2023 (InvestorPlace)
Feb-20-24 08:30AM Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors (GlobeNewswire)
Jan-03-24 04:15PM Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4) (GlobeNewswire)
Dec-21-23 11:18AM Eterna Therapeutics Appoints Sanjeev Luther as President and CEO (Exec Edge)
Dec-20-23 04:15PM Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer (GlobeNewswire) +9.87%
GDTC - CytoMed Therapeutics Ltd - Stock Price Chart
TickerGDTC [NASD]
CompanyCytoMed Therapeutics Ltd
CountrySingapore
IndustryBiotechnology
Market Cap25.85MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B3.03EPS Q/Q9.49%
Dividend-Sales Q/Q-
Insider Own59.01%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.83%EarningsMay 29
Analyst Recom1.00Target Price5.00
Avg Volume66.31K52W Range1.89 - 5.50
Jul-17-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now (GlobeNewswire) +14.29%
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (?d) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta ( ) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
Jul-16-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 1 on July 17 Register Now (GlobeNewswire)
Mar-20-24 08:30AM CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration (ACCESSWIRE) -5.60%
Mar-18-24 06:00AM CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies (GlobeNewswire) +5.63%
Mar-04-24 05:00AM CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair (GlobeNewswire)
Jan-29-24 07:00AM Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology (GlobeNewswire)
Dec-05-23 07:30AM CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology (PR Newswire)
Nov-17-23 09:21AM CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update (PR Newswire) -8.60%
MLGO - MicroAlgo Inc - Stock Price Chart
TickerMLGO [NASD]
CompanyMicroAlgo Inc
CountryChina
IndustrySoftware - Infrastructure
Market Cap21.38MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.20EPS Q/Q-224.96%
Dividend-Sales Q/Q-
Insider Own77.57%Inst Own0.14%
Insider Trans0.00%Inst Trans-0.51%
Short Float134.57%Earnings-
Analyst Recom-Target Price-
Avg Volume9.25M52W Range1.56 - 156.00
AEHL - Antelope Enterprise Holdings Ltd - Stock Price Chart
TickerAEHL [NASD]
CompanyAntelope Enterprise Holdings Ltd
CountryChina
IndustryBuilding Products & Equipment
Market Cap37.75MEPS (ttm)-3.79
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y57.87%
P/S0.52EPS next 5Y-
P/B0.87EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own54.07%Inst Own0.25%
Insider Trans0.00%Inst Trans120.52%
Short Float2.11%EarningsMay 07/b
Analyst Recom-Target Price-
Avg Volume295.09K52W Range1.22 - 8.70
12345671020